Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Globe Biomedical is a medical technology company focused on revolutionizing the management of glaucoma through continuous monitoring and personalized treatment. The company's flagship technology is a non-invasive, wearable device designed to monitor intraocular pressure (IOP) around the clock, providing clinicians with critical data that traditional office-based measurements miss. By capturing diurnal variations and pressure spikes, Globe Biomedical aims to prevent vision loss and optimize therapy for patients with glaucoma and ocular hypertension. The company is a spin-out from the University of Utah, leveraging advanced sensor technology and data analytics to improve ocular health outcomes. Its platform integrates wearable hardware with cloud-based analytics to offer a comprehensive remote monitoring solution for ophthalmologists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Globe Biomedical.